Feline non-regenerative immune-mediated anaemia: features and outcome in 15 cases
- PMID: 26116621
- PMCID: PMC10816389
- DOI: 10.1177/1098612X15588800
Feline non-regenerative immune-mediated anaemia: features and outcome in 15 cases
Abstract
Objectives: Pure red cell aplasia (PRCA) and non-regenerative immune-mediated haemolytic anaemia (NRIMHA) are uncommon causes of non-regenerative anaemia affecting the bone marrow in the cat. This retrospective study aimed to describe the clinical features, treatment and outcome (remission and survival) of cats with these disorders.
Methods: Cases of PRCA and NRIMHA presenting between 2009 and 2013 were retrieved. Clinical features including signalment, history, clinical signs and diagnostic investigations were recorded, as well as treatment(s) used and outcome (remission and survival). Outcome was compared for PRCA and NRIMHA.
Results: Fifteen cats met inclusion criteria: seven with PRCA and eight with NRIMHA. The majority (12/15) were younger than 3 years of age. Volume overload was common (8/11). Treatment with whole blood transfusions with or without Oxyglobin was necessary in most cats (14/15) and resulted in congestive heart failure in one cat. Most cats (11/15) achieved remission 12-42 days after starting immunosuppressive treatment. Treatment protocols associated with remission were glucocorticoids alone (remission in 6/7 cats), glucocorticoids and chlorambucil (remission in 3/6 treated cats), glucocorticoids and ciclosporin (one cat only) and ciclosporin alone (one cat only). Relapse was observed in 3/11 cats, and 8/11 cats were still receiving treatment at the time of follow-up. Outcome (remission and survival) did not differ between PRCA and NRIMHA.
Conclusions and relevance: PRCA and NRIMHA are uncommon causes of anaemia in predominantly young cats. The prognosis is reasonable, with a mortality rate of 27%, and it can take at least 6 weeks before remission is observed. Following clinical remission, gradual withdrawal of immunosuppressive treatments should be attempted, with close monitoring for relapse; some cats may require long-term treatment. This study is the first to report the use of chlorambucil as an adjunctive immunosuppressant in these cases. Outcome did not differ for PRCA and NRIMHA.
© ISFM and AAFP 2015.
Conflict of interest statement
The authors do not have any potential conflicts of interest to declare.
References
-
- Barker RN, Gruffydd-Jones TJ, Stokes CR, et al. . Autoimmune haemolysis in the dog: relationship between anaemia and the levels of red blood cell bound immunoglobulins and complement measured by an enzyme-linked antiglobulin test. Vet Immunol Immunopathol 1992; 34: 1–20. - PubMed
-
- Werner LL, Gorman NT. Immune-mediated disorders of cats. Vet Clin North Am Small Anim Pract 1984; 14: 1039–1064. - PubMed
-
- Scott DW, Schultz RD, Post JE, et al. . Autoimmune haemolytic anaemia in the cat. J Am Anim Hosp Assoc 1973; 9: 530–539.
-
- Meyer D, Harvey JW. Veterinary laboratory medicine: interpretation and diagnosis. In: Veterinary laboratory medicine: interpretation and diagnosis. 3rd ed. St Louis, MO: Saunders, 2004, pp 69–79.
-
- Weiss DJ. Bone marrow pathology in dogs and cats with non-regenerative immune-mediated haemolytic anaemia and pure red cell aplasia. J Comp Pathol 2008; 138: 46–53. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous